Phibro Animal Health Corp. (NASDAQ:PAHC)’s share price traded up 2.5% during trading on Wednesday . The company traded as high as $21.51 and last traded at $21.44, with a volume of 67,284 shares trading hands. The stock had previously closed at $20.92.

A number of equities analysts have commented on the stock. Zacks Investment Research lowered shares of Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday. Morgan Stanley reiterated a “sell” rating on shares of Phibro Animal Health Corp. in a research report on Thursday, May 12th. TheStreet lowered shares of Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research report on Thursday, June 9th. Finally, Guggenheim reiterated a “buy” rating and set a $26.00 target price (down from $34.00) on shares of Phibro Animal Health Corp. in a research report on Friday, May 13th. Four investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $35.33.

The firm has a market capitalization of $819.27 million and a price-to-earnings ratio of 10.66. The firm has a 50 day moving average price of $20.69 and a 200-day moving average price of $22.46.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 28th. Investors of record on Wednesday, September 7th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date is Friday, September 2nd.

Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.